Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Phosphorylated Derivatives of Exopolysaccharide from Trichomonas granulosa and Its Application in the Preparation of Antitumor Drugs

A technology of exopolysaccharides and Trichomonas granulosa, applied in the direction of anti-tumor drugs, drug combinations, pharmaceutical formulas, etc., to achieve the effects of no toxic side effects, significant anti-tumor functions, and simple and economical preparation methods

Inactive Publication Date: 2015-09-16
HEFEI UNIV OF TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far there is no public literature mentioning the phosphorylated derivatives of Trichomonas exopolysaccharide and its application as an anti-tumor drug.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phosphorylated Derivatives of Exopolysaccharide from Trichomonas granulosa and Its Application in the Preparation of Antitumor Drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] 1. Preparation of exopolysaccharide from Trichomonas granulosa:

[0016] The culture preservation number is CCTCC No: M2011196 Trichomonas inoculated in 5L fermenter, medium formula is: glucose 40g / L, yeast extract 12g / L, glycine 6.2mg / L, MgSO4 7H2O 1g / L, KH2PO4 1g / L, the volume ratio of the loading factor is 0.7, the inoculum size is 15% (volume ratio), the culture temperature is 35°C, the ventilation rate is 1.0L / min, the stirring speed is 180r / min, and the fermentation time is 10 days; After suction filtering and concentrating the fermentation broth, add 3 times its volume of ethanol with a mass fraction of 95% and alcohol precipitation at 4°C for 24 hours, centrifuge the ethanol solution at 5000r / min for 10min, remove the supernatant, and precipitate with absolute ethanol, Wash with acetone for 2 to 3 times, then dissolve with distilled water, deproteinize by Sevag method and decolorize with 30% H2O2 (50°C) by volume percent concentration, dialyze with distilled wat...

Embodiment 2

[0052] Firstly, prepare and obtain the exopolysaccharide of Trichodia granulosa according to the following conditions and methods: inoculate Trichodia granulosa exopolysaccharide with strain preservation number CCTCC No: M2011196 in a 4L fermenter, and the medium formula is: glucose 44g / L, yeast extract 12g / L, glycine 6.5mg / L, MgSO4 7H2O 1.2g / L, KH2PO4 1.2g / L, the volume ratio of the loading coefficient is 0.6, the inoculum size is 14% (volume ratio), the culture temperature is 30°C, and the ventilation rate is 1.1L / min, the stirring speed is 175r / min, and the fermentation time is 8 days; after the fermentation broth is suction-filtered and concentrated, 2 times its volume of ethanol with a mass fraction of 95% is added to alcohol precipitation at 4°C for 30h, and the alcohol is separated The solution was centrifuged at 5000r / min for 8min, the supernatant was removed, the precipitate was washed 3 times with absolute ethanol and acetone, and then dissolved in distilled water, d...

Embodiment 3

[0057] Example 3: Processing of Phosphorylated Derivatives of Exopolysaccharides from Trichomonas granulosa

[0058] In the present invention, the exopolysaccharide phosphorylated derivatives produced by Trichodia granulosa with the strain preservation number of CCTCC No: M2011196 are used as the preparation of anti-tumor drugs, which can be formulated and processed into the following dosage forms for use:

[0059] 1. Tablet processing

[0060] Mix 300-600g of phosphorylated exopolysaccharide derivatives of Trichodia granulosa with 200-250g of pharmaceutical excipient diluent and 30-60g of glidant, and then mix them with 250-600mL of ethanol to obtain a soft material. Wet granules are obtained by sieving, granulated after drying, and finally 3-10 g of lubricant is added, mixed evenly, and compressed into tablets to make 1000 tablets. The pharmaceutical excipient diluent is dextrin or dry starch; the glidant is talcum powder or micropowder silica gel or microcrystalline cellul...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of lachnum extracellular polysaccharide phosphorylated derivative and an application thereof in preparation of antitumor drugs. The lachnum extracellular polysaccharide phosphorylated derivative is obtained by performing phosphorylated decoration on extracellular polysaccharide generated by lachnum with strain preservation number of CCTCC No: M2011196. As shown by an experiment, the extracellular polysaccharide phosphorylated derivative generated by lachnum with strain preservation number of CCTCC No: M2011196 not only has excellent antitumor function, but also has no toxicity or side effect, and the preparation method is simple and economic, so that the lachnum extracellular polysaccharide phosphorylated derivative can be used for preparing tablet or capsule antitumor drugs.

Description

technical field [0001] The invention relates to a phosphorylated derivative of the extracellular polysaccharide of Trichomona granulosa and its application in the preparation of antitumor drugs. Background technique [0002] Malignant tumor is one of the common clinical diseases, and it is also one of the main causes of human death. At present, the treatment of malignant tumors mainly adopts methods such as radiotherapy and chemotherapy. The commonly used chemotherapeutic drugs are mostly chemically synthesized substances rather than natural products. Therefore, while killing tumor cells, they also have a certain degree of killing effect on normal cells; and simple Chemotherapy can cause loss of appetite and weight loss in patients, leading to weakening of the body, and causing a certain degree of immunosuppression, with relatively large toxic and side effects. Therefore, excavating and developing natural, non-toxic anti-tumor drugs is of great significance for maintaining ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08B37/00A61K31/715A61P35/00
Inventor 叶明袁如月杜湛湛
Owner HEFEI UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com